10:20 PM IST
Allergan Plc on Wednesday said it plans to cut over 1,000 jobs and eliminate an additional 400 currently open positions, as it works to cut costs in the face of new competition for its second most important drug, dry-eye treatment Restasis.
The company said the jobs and positions it plans to eliminate mostly focus on products and categories where the company has or expects to soon lose exclusivity.
The drugmaker said it expects to take a $125 million charge from the job cuts, primarily due to severance, most of which will be recorded in the fourth quarter of 2017.
Allergan said cost savings from this restructuring programme should be around $300 million to $400 million per year.
(This article has not been edited by Zeebiz editorial team and is auto-generated from an agency feed.)
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
RECOMMENDED STORIES
)
8th Pay Commission Revised Salary Calculations: Is your Grade Pay Rs 2,000, Rs 4,200, Rs 5,400 or Rs 6,600? Know projected revised salary, HRA, TA, NPS, CGHS contributions at 2.28 fitment factor
)
Power of Rs 6,000 SIP: How many years can it take to generate Rs 5,00,00,000 corpus with just Rs 6,000 monthly investment?
)
Power of Compounding: How soon can you expect to generate Rs 3,00,00,000 corpus with Rs 4 lakh lump sum investment?
)
Anil Singhvi suggests selling 1 largecap, 1 midcap and 2 smallcap stocks after weak Q4 results; check target, stop loss
10:20 PM IST